Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 3 189 4043 186 2313 105 3953 087 122--
Entreprise Value (EV)1 2 844 1562 875 1572 777 5452 647 1302 547 6802 433 719
P/E ratio 19,9x14,4x16,0x16,5x13,6x12,7x
Yield 2,23%2,29%-2,53%2,73%2,96%
Capitalization / Revenue 2,45x2,44x2,39x2,43x2,30x2,21x
EV / Revenue 2,19x2,20x2,14x2,09x1,90x1,75x
EV / EBITDA 10,2x9,35x8,95x8,69x7,28x6,63x
Price to Book 2,51x2,49x2,41x2,23x2,07x1,93x
Nbr of stocks (in thousands) 1 976 0871 921 1521 858 4051 857 474--
Reference price (JPY) 1 6141 6591 6711 6621 6621 662
Last update 04/26/201804/25/201905/14/202001/15/202101/15/202101/15/2021
1 JPY in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 1 300 3161 306 3481 300 8431 269 2811 342 7811 393 966
EBITDA1 278 121307 370310 387304 771350 091367 046
Operating profit (EBIT)1 213 258243 912243 991231 884279 048290 991
Operating Margin 16,4%18,7%18,8%18,3%20,8%20,9%
Pre-Tax Profit (EBT)1 218 113248 967245 350230 198277 996289 379
Net income1 164 679222 265195 411184 530224 157235 046
Net margin 12,7%17,0%15,0%14,5%16,7%16,9%
EPS2 81,1115104101122131
Dividend per Share2 36,038,0-42,145,449,2
Last update 04/26/201804/25/201905/14/202001/15/202101/15/202101/15/2021
1 JPY in Million
2 JPY
Estimates
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 345 248311 074327 850439 991539 441653 402
Leverage (Debt / EBITDA) -1,24x-1,01x-1,06x-1,44x-1,54x-1,78x
Free Cash Flow1 190 815233 440-167 795183 725220 743206 652
ROE (Net Profit / Equities) 13,0%17,6%15,3%14,0%16,0%15,9%
Shareholders' equity1 1 266 7621 262 8691 277 1961 321 1921 399 3811 482 313
ROA (Net Profit / Asset) 11,9%13,3%11,6%9,10%9,33%9,27%
Assets1 1 388 8931 676 5161 678 8582 027 8062 401 6882 536 461
Book Value Per Share2 642667694745803862
Cash Flow per Share2 113148140139150146
Capex1 25 07725 19041 26751 33345 00045 000
Capex / Sales 1,93%1,93%3,17%4,04%3,35%3,23%
Last update 04/26/201804/25/201905/14/202001/15/202101/15/202101/15/2021
1 JPY in Million
2 JPY
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (JPY)
3 087 121 635 096
Capitalization (USD)
29 741 629 271
Net sales (JPY)
1 300 843 000 000
Net sales (USD)
12 519 313 032
Number of employees
15 883
Sales / Employee (JPY)
81 901 593
Sales / Employee (USD)
788 221
Free-Float
99,2%
Free-Float capitalization (JPY)
3 062 184 503 244
Free-Float capitalization (USD)
29 501 382 524
Avg. Exchange 20 sessions (JPY)
7 200 847 680
Avg. Exchange 20 sessions (USD)
69 300 958
Average Daily Capital Traded
0,2%
EPS & Dividend